1-8 of 8
E Salzman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASBMT Risk Group and CD 34+ Dose Predicted for the Development of aGVHD in Allogeneic MRD Transplants When the Donors Who Received a Combined Mobilization and In Vivo TCD Regimen Using rhg-CFS and Dexamethasone.

Khaleel K. Ashraf, MD, Arabella B. Tilden, PhD, Yufeng Li, PhD, Sameer Gupta, MD, Lawrence S. Lamb, PhD, Donna E. Salzman, MD, Richard Lopez, MD, William P. Vaughan, MD
Journal: Blood
Blood (2007) 110 (11): 5006.
https://doi.org/10.1182/blood.V110.11.5006.5006
Published: 2007
Journal Articles

Use of Dexamethasone Given to Sibling Donors as a Way of In Vivo Purging of Allo Reactive Donor T Cells in rhg-CSF Mobilized Peripheral Blood Stem Cell Transplantations Resulted in Significant Decrease in CD3+ Cells and Increased CD34+ Yield.

Khaleel K. Ashraf, MD, Arabella B. Tilden, PhD, Yufeng Li, PhD, Lawrence Lamb, PhD, Donna E. Salzman, MD, Matthew H. Carabasi, MD, Richard Lopez, MD, William P. Vaughan, MD
Journal: Blood
Blood (2007) 110 (11): 3047.
https://doi.org/10.1182/blood.V110.11.3047.3047
Published: 2007
Journal Articles

Decreased Acute but Not Chronic Graft Versus Host Disease (GVHD) after Allogeneic (ALLO) Hematopoietic Stem Cell Transplant (HSCT) from Matched Sibling Donors (MRD) Using Peripheral Blood Progenitor Cells (PBPC) Mobilized with Filgastrim (GCSF) Plus Dexamethasone (DEX).

Sameer Gupta, MBBS, Arabella B. Tilden, PhD, William P. Vaughan, MD, Donna E. Salzman, MD, Lawrence S. Lamb, PhD, Rhonda O. Katz, CRNP, Matthew H. Carabasi, MD
Journal: Blood
Blood (2004) 104 (11): 3342.
https://doi.org/10.1182/blood.V104.11.3342.3342
Published: 2004
Journal Articles

Improving Dosing Precision in Buslfan (BU) Based Preparative Regimens for Hematopoietic Stem Cell Transplantation (HSCT).

William P. Vaughan, MD, Amy G. Nance, CRNP, Donna E. Salzman, MD
Journal: Blood
Blood (2004) 104 (11): 1148.
https://doi.org/10.1182/blood.V104.11.1148.1148
Published: 2004
Journal Articles

Improved Outcomes of Autologous (Auto) Hematopoeitic Stem Cell Transplantation (HSCT) for Intermediate and High Risk (I/HR) Aggressive (AG) Non Hodgkin Lymphoma (NHL) with IV vs PO Busulfan (Bu) in a Bu, Cyclophosphamide (Cy) and Etoposide (E) Preparative Regimen.

Charu Aggarwal, MBBS, Sameer Gupta, MBBS, Donna E. Salzman, MD, Amy G. Dickey, CRNP, William P. Vaughan, MD
Journal: Blood
Blood (2004) 104 (11): 1881.
https://doi.org/10.1182/blood.V104.11.1881.1881
Published: 2004
Journal Articles

Fatal sickle cell crisis after granulocyte colony-stimulating factor administration

Brian K. Adler, Donna E. Salzman, Matthew H. Carabasi, William P. Vaughan, Vishnu V. B. Reddy, Josef T. Prchal
Journal: Blood
Blood (2001) 97 (10): 3313–3314.
https://doi.org/10.1182/blood.V97.10.3313
Published: 2001
Journal Articles

Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate

M Weinstein, JA Ware, J Troll, E Salzman
Journal: Blood
Blood (1988) 71 (6): 1648–1655.
https://doi.org/10.1182/blood.V71.6.1648.1648
Published: 1988
Journal Articles

Intermediate syndrome of platelet dysfunction

EE Czapek, D Deykin, E Salzman, EC Lian, LJ Hellerstein, CB Rosoff
Journal: Blood
Blood (1978) 52 (1): 103–113.
https://doi.org/10.1182/blood.V52.1.103.103
Published: 1978